期刊文献+

心脏性猝死高危患者发生新发心房颤动的临床预后

Prognostic impact of new-onset atrial fibrillation in patients at high risks of sudden cardiac death
原文传递
导出
摘要 目的探究新发心房颤动(房颤)、不同种类新发房颤、不同新发房颤持续时间对心脏性猝死高危人群远期预后的影响。方法本研究为回顾性队列研究。选取"心脏植入电子设备患者的家庭监测系统安全性和有效性研究"注册研究中2010年5月至2014年4月植入心律转复除颤器(ICD)或心脏再同步治疗除颤器(CRT-D)患者存档的家庭监测数据进行回顾性分析。将ICD或CRT-D植入后首次检测到的每日≥1%心房高频事件负荷,无论是否有症状,定义为新发房颤。通过构建新发房颤作为时依协变量的Cox比例风险模型,评估其对心源性死亡和全因死亡的影响。结果纳入343例配备家庭监测系统的ICD/CRT-D植入术后患者,年龄(62.5±13.5)岁,其中男占77.6%(266/343),左心室射血分数39.1%±14.6%。随访(50.3±17.8)个月,新发房颤124例(36.2%,124/343),87例(25.4%,87/343)全因死亡,其中心源性死亡61例(17.8%,61/343)。多因素Cox比例风险模型分析显示,新发房颤患者是无新发房颤患者发生心源性死亡(HR=2.15,95%CI 1.24~3.71,P=0.006)和全因死亡(HR=2.16,95%CI 1.36~3.44,P=0.001)风险的2.2倍;新发房颤类型为持续性房颤(HR=2.68,95%CI 1.32~5.42,P=0.006)或新发房颤最长持续时间≥7 d者(HR=2.72,95%CI 1.40~5.29,P=0.003)发生心源性死亡风险显著增加,其发生风险是无新发房颤患者的2.7倍。结论新发房颤的心脏性猝死高危人群远期死亡风险显著升高,尤其是新发持续性房颤可使远期心源性死亡风险进一步升高。 Objective To evaluate the impact of new-onset atrial fibrillation(AF),its different types and different AF duration on long-term prognosis in patients with high risks of sudden cardiac death(SCD).Methods This study was a retrospective cohort study.Patients from the Study of Home Monitoring System Safety and Efficacy in Cardiac Implantable Electronic Device-implanted Patients(SUMMIT)registry receiving implantable cardioverter defibrillator(ICD)or cardiac resynchronization therapy defibrillator(CRT-D)implantation between May 2010 and April 2014 were retrospectively analyzed using archived home monitoring data.New-onset AF was defined as the first atrial high-rate episode(AHRE)with≥1%daily burden after ICD/CRT-D implantation,whether it was symptomatic or not.The Cox proportional hazard models were constructed using new-onset AF as a time-varying covariate to explore its effects on long-term cardiac death and all-cause mortality.Results Three hundred and forty-three patients receiving ICD or CRT-D implantation equipped with home monitoring system were included,with age(62.5±13.5)years old,male 77.6%(266/343),left ventricular ejection fraction(LVEF)39.1%±14.6%.During a follow-up duration of(50.3±17.8)months,124(36.2%,124/343)cases of new-onset AF and 87(25.4%,87/343)deaths occurred.Of these,61(17.8%,61/343)patients died from cardiac causes.The multivariate Cox regression analysis showed that the risks of cardiac death(HR=2.15,95%CI 1.24-3.71,P=0.006)and all-cause mortality(HR=2.16,95%CI 1.36-3.44,P=0.001)were 2.2 times in patients with new-onset AF as high as those who did not experience new-onset AF.And the risks of cardiac death increased significantly in patients who new-onset persistent AF occurred(HR=2.68,95%CI 1.32-5.42,P=0.006)or had a≥7 day AF duration(HR=2.72,95%CI 1.40-5.29,P=0.003),which was 2.7 times as high as those who did not experience new-onset AF.Conclusion For patients at high risk for SCD who experienced new-onset AF,the risk of long-term cardiac death is further significantly increased,especially in patients with new persistent AF.
作者 孙雪荣 赵爽 张澍 刘兴鹏 Sun Xuerong;Zhao Shuang;Zhang Shu;Liu Xingpeng(Heart Center and Beijing Key Laboratory of Hypertension,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China;Center of Arrhythmia,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100037,China)
出处 《中华心律失常学杂志》 2024年第3期224-229,共6页 Chinese Journal of Cardiac Arrhythmias
基金 北京朝阳医院金种子科研(CYJZ202205)。
关键词 心房颤动 新发 心脏性猝死 心源性死亡 全因死亡 家庭监测系统 Atrial fibrillation New-onset Sudden cardiac death Cardiac death All-cause death Home-monitoring system
  • 相关文献

参考文献2

二级参考文献35

  • 1王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 2Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities:a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines. ( Writ- ing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 : e1-62.
  • 3Dickstein K,Vardas PE,Aurlcchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribu- tion of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail,2010,12 : 1143-1153.
  • 4McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute mad chronic heart failure 2012. Eur J Heart Fail,2012,14 : 803- 869.
  • 5Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert con- sensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs) : Description of techniques, indications, person- nel, frequency and ethical considerations. Europace, 2008, 10: 707-725.
  • 6Haycs DL, Naccarelli GV, Fuman S, et al. North American Society to Pacing and Electrophysiology. NASPE training requirements for cardiae implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Eleetrophysiol,2003,26 : 1556-1562.
  • 7Naccarelli GV,Conti JB, DiMarco JP,et al. 2008 COCATS 3 Tack Force 6: training in specialized electrophysiology,cardiac pacing, and arrhythmia management. Heart Rhythm ,2008,5:332-337.
  • 8Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol, 2005,28 : 235 -240.
  • 9Joseph GK, Wilkoff BL, Dresing T, et al. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol,2004,11 : 161-166.
  • 10Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of au- tomatic remote monitoring for implantable cardioverter-defibrilla- tot follow-up: The Lumos-T Safely Reduces Routine Office De- vice Follow-up (TRUST) trial. Circulation,2010,122:325-332.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部